Jinhai Medical Reports Expected Loss Amid Growth

Jinhai International Group Holdings Limited (HK:2225) has released an update.

Jinhai Medical Technology Limited has issued a profit warning, announcing an expected loss of around S$6.0 million for the first half of 2024, a significant downturn from the S$590,000 profit reported in the same period of 2023. Despite the loss, the company’s revenue and gross profit showed positive growth, with the loss largely attributed to substantial expenses related to share-based payments for employee share options. Investors are cautioned to exercise care when dealing in the company’s shares as the interim financial results are yet to be finalized.

For further insights into HK:2225 stock, check out TipRanks’ Stock Analysis page.